Back to Dividend Stocks
Novo Nordisk A/S (NOVO.B.CO) logo

Novo Nordisk A/S

EURO STOXX 600

NOVO.B.CO/Healthcare · Drug Manufacturers - General/NASDAQ Copenhagen

Dividend Yield

3.82%

DKK 11.70 · Annual Dividend

Stock PriceDKK 315.65P/E11.1MCap1.6TLast update: Jun 26, 2026 at 06:56

Dividend Safety Rating

82/ 100Very Safe

NOVO.B.CO's dividend appears very safe. Strengths include a 42.7% earnings payout ratio & 34.6% cfo payout ratio. Areas of concern: 167.7% fcf payout ratio & 0.8x current ratio. The dividend has been growing at a 40.21% 5-year CAGR.

Based on 15 of 15 metrics

Strengths

  • Earnings Payout Ratio: 42.7%Low earnings payout ratio leaves room to grow the dividend.
  • Interest Coverage: 32.0xEarnings cover interest payments many times over.
  • Return on Equity: 71.4%Strong return on equity reflects efficient profit generation.

Risks

  • FCF Payout Ratio: 167.7%Free cash flow is tight relative to the dividend.
  • Current Ratio: 0.8xLimited short-term liquidity to meet obligations.

Payout & Coverage

Safe
42.7%Very Safe
167.7%Danger
32.0xVery Safe

Balance Sheet

Caution

Profitability

Very Safe
71.4%Very Safe
61.6%Very Safe
86.0%Very Safe
Very StableVery Safe

Dividend Track Record

Very Safe
10+ yrsVery Safe
NoneVery Safe
40.2%Very Safe
GrowingVery Safe

About Novo Nordisk A/S

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; and growth hormone pens and injection needles. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Dividend Overview

Dividend Yield

3.82%

Annual Dividend

DKK 11.70

Frequency

Semi-Annual

Payout Ratio

42.69%

FCF Payout Ratio

167.70%

52-Week Range

DKK 224.25 - DKK 464.60

Dividend History (2016–2025)

NOVO.B.CO annual dividend per share and yield history

Earnings & Profitability

NOVO.B.CO earnings per share and net profit margin

Key Dates

Last Ex-Dividend Date

March 27, 2026

Next Payment Date

Dividend Growth

3-Year Dividend CAGR

61.08%

5-Year Dividend CAGR

40.21%

10-Year Dividend CAGR

N/A

3-Year Total Growth

317.94%

5-Year Total Growth

441.86%

10-Year Total Growth

N/A

Income Calculator

NOVO.B.CO Dividend Calculator

Total Investment

DKK 31,565.00

Annual Income

DKK 1,170.00

Quarterly Income

DKK 292.50

Monthly Income

DKK 97.50

Frequently Asked Questions

What is NOVO.B.CO's current dividend yield?
Novo Nordisk A/S (NOVO.B.CO) currently has a dividend yield of 3.82%, based on a stock price of DKK 315.65 and an annual dividend of DKK 11.70.
When is NOVO.B.CO's next dividend payment date?
NOVO.B.CO's next ex-dividend date is 2026-03-27 and the next payment date is —. You must own the stock before the ex-dividend date to receive the upcoming payment.
How much does NOVO.B.CO pay in dividends per year?
Novo Nordisk A/S paid DKK 11.65 per share in annual dividends in 2025. The dividends are paid semi-annual.
Has NOVO.B.CO been increasing its dividend?
Novo Nordisk A/S has grown its dividend at a 5-year CAGR of 40.21%.
Is NOVO.B.CO's dividend safe?
Novo Nordisk A/S has a payout ratio of 42.69%. Its free cash flow payout ratio is 167.70%. A payout ratio below 60% is generally considered sustainable.
How is NOVO.B.CO's Dividend Safety Rating calculated?
The Dividend Safety Rating evaluates Novo Nordisk A/S's dividend sustainability across four categories: Payout & Coverage (30%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (30%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track NOVO.B.CO Dividends with OnlyDividends

What will NOVO.B.CO actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

Download the App

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.